Ryan Gerbrandt - Oct 4, 2024 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Chief Operating Officer
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Stock symbol
ATEX
Transactions as of
Oct 4, 2024
Transactions value $
$0
Form type
4
Date filed
10/8/2024, 05:56 PM
Previous filing
Jul 15, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +61.5K $0.00 61.5K Oct 4, 2024 Common Stock 61.5K $35.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares vest on the third anniversary of the grant date, subject to (i) the Reporting Person's continued service with the Issuer through this date and (ii) the Issuer's common stock achieving a specified price per share during the three-year period.